My Quote Request
No products added yet
6505-01-189-9903
20 Products
VICODIN TABLETS
HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505011899903
NSN
6505-01-189-9903
VICODIN TABLETS
HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505011899903
NSN
6505-01-189-9903
MFG
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HYDROCODONE BITARTRATE ACTIVE INGREDIENT AND 500.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: WITH TAMPER EVIDENT SEAL
Related Searches:
VICODIN
HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505011899903
NSN
6505-01-189-9903
VICODIN
HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505011899903
NSN
6505-01-189-9903
MFG
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HYDROCODONE BITARTRATE ACTIVE INGREDIENT AND 500.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: WITH TAMPER EVIDENT SEAL
Related Searches:
04-320
DETERGENT
NSN, MFG P/N
6505011900090
NSN
6505-01-190-0090
MFG
FISHER SCIENTIFIC COMPANY L.L.C.
Description
DETERGENT
Related Searches:
CAPOTEN
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 25MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CAPOTEN TABLETS
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
CAPOTEN TABLETS
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 25MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00003-0452-75
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
NDC00003-0452-75
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 25MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-8133-10
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
NDC00093-8133-10
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
MFG
LEMMON CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 25MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC49884-0794-10
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
NDC49884-0794-10
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505011900669
NSN
6505-01-190-0669
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 25MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MONOCID
CEFONICID SODIUM,ST
NSN, MFG P/N
6505011902842
NSN
6505-01-190-2842
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 500 MG CEFONICID SODIUM ACTIVE INGREDIENT; POWDER; 10 ML VIAL; FOR INTRAMUSCULAR OR INTRAVENOUS USE AFTER RECONSTITUTION; MUST BE REFRIGERATED
Related Searches:
NDC00007-4351-01
CEFONICID SODIUM,ST
NSN, MFG P/N
6505011902842
NSN
6505-01-190-2842
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 500 MG CEFONICID SODIUM ACTIVE INGREDIENT; POWDER; 10 ML VIAL; FOR INTRAMUSCULAR OR INTRAVENOUS USE AFTER RECONSTITUTION; MUST BE REFRIGERATED
Related Searches:
NDC00003-1835-10
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505011903582
NSN
6505-01-190-3582
NDC00003-1835-10
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505011903582
NSN
6505-01-190-3582
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN ZINC SUSPENSION USP 100UN/ML 10ML MULTI DOSE VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: NOVOLIN BY NOVO NORDISK
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: RECOMBINANT DNA ORIGIN (YEAST)
Related Searches:
NDC00169-1835-11
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505011903582
NSN
6505-01-190-3582
NDC00169-1835-11
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505011903582
NSN
6505-01-190-3582
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN ZINC SUSPENSION USP 100UN/ML 10ML MULTI DOSE VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: NOVOLIN BY NOVO NORDISK
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: RECOMBINANT DNA ORIGIN (YEAST)
Related Searches:
NOVOLIN-L
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505011903582
NSN
6505-01-190-3582
NOVOLIN-L
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505011903582
NSN
6505-01-190-3582
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN ZINC SUSPENSION USP 100UN/ML 10ML MULTI DOSE VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: NOVOLIN BY NOVO NORDISK
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: RECOMBINANT DNA ORIGIN (YEAST)
Related Searches:
NDC52604-0460-01
CHLORPHENIRAMINE MALEATE,METHSCOPOLAMINE NITRATE,AND PHENYLEPHRINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505011904395
NSN
6505-01-190-4395
NDC52604-0460-01
CHLORPHENIRAMINE MALEATE,METHSCOPOLAMINE NITRATE,AND PHENYLEPHRINE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505011904395
NSN
6505-01-190-4395
MFG
MONARCH PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.000 MILLIGRAMS CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS METHSCOPOLAMINE NITRATE ACTIVE INGREDIENT AND 20.000 MILLIGRAMS PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORPHENIRAMINE MALEATE METHSCOPOLAMINE NITR & PHENYL HCL CAPSULES 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00409-7973-05
WATER FOR IRRIGATION,STERILE,USP
NSN, MFG P/N
6505011904398
NSN
6505-01-190-4398
NDC00409-7973-05
WATER FOR IRRIGATION,STERILE,USP
NSN, MFG P/N
6505011904398
NSN
6505-01-190-4398
MFG
HOSPIRA INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: WATER FOR IRRIGATION STERILE USP 1000 ML 12S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH HANGING DEVICE AND TWO PORTS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
6505-00-C04-0010
NETILMICIN SULFATE INJECTION
NSN, MFG P/N
6505011904399
NSN
6505-01-190-4399
6505-00-C04-0010
NETILMICIN SULFATE INJECTION
NSN, MFG P/N
6505011904399
NSN
6505-01-190-4399
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150 MG/ML NETILMICIN SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00085-0264-02
NETILMICIN SULFATE INJECTION
NSN, MFG P/N
6505011904399
NSN
6505-01-190-4399
NDC00085-0264-02
NETILMICIN SULFATE INJECTION
NSN, MFG P/N
6505011904399
NSN
6505-01-190-4399
MFG
SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150 MG/ML NETILMICIN SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NETROMYCIN
NETILMICIN SULFATE INJECTION
NSN, MFG P/N
6505011904399
NSN
6505-01-190-4399
NETROMYCIN
NETILMICIN SULFATE INJECTION
NSN, MFG P/N
6505011904399
NSN
6505-01-190-4399
MFG
SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150 MG/ML NETILMICIN SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00005-5362-23
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011906285
NSN
6505-01-190-6285
NDC00005-5362-23
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011906285
NSN
6505-01-190-6285
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.100 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.12 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-2713-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011906285
NSN
6505-01-190-6285
NDC00781-2713-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011906285
NSN
6505-01-190-6285
MFG
GENEVA PHARMACEUTICALS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.100 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.01 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.12 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE CAPSULES USP 50MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
